Pharmaceuticals - Community Register

  

Community list of not active medicinal products for human use


WITHDRAWN  

Product information

Invented name: Ecokinase
Auth. number : EU/1/96/017
INN : Reteplase
ATC: Anatomical main group: B - Blood and blood forming organs
Therapeutic subgroup: B01 - Antithrombotic agents
Pharmacological subgroup: B01A - Antithrombotic agents
Chemical subgroup: B01AD - Enzymes
Chemical substance: B01AD07 - Reteplase
(See WHO ATC Index)
Indication: Thrombolytic therapy of acute myocardial infarction (AMI) (within 12 hours after the onset of AMI symptoms)
Marketing Authorisation Holder: Galenus Mannheim GmbH
Sandhofer Straße 116, D-68298 Mannheim, Deutschland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/08/1996 Centralised - Authorisation EMEA/H/C/106 (96)2453 of 29/08/1996
05/08/1999 Centralised - Withdrawal (1999)2569 of 30/07/1999